News and events

Published Nov. 6, 2019 11:14 AM

Yearly, the Norwegian Cancer Society yields grants to cancer research, this year 15 projects divided into three categories: “more knowledge”, “better treatment”, and “a life with and after cancer”.

Fridtjof Lund-Johansen received a grant of 5,33 million NOK from the Norwegian Cancer Society to identify cancer-specific peptides to find better treatments for cancer patients.

Published Sep. 10, 2019 9:25 AM

JCIT partner Fridtjof Lund-Johansen fikk sammen med 10 andre norske proteomikk-forskere tilslag fra Norges Forskningsråd på en søknad om 100 millioner til massespektrometriutstyr. Massespektrometri er bl.a. helt sentralt for å kartlegge molekyler som kan være mål for immunterapi mot kreft, og JCIT har en stor satsning innen dette området. 

Published Sep. 10, 2019 9:20 AM

Med støtte fra Radiumhospitalets Legat har Karl-Johan Malmberg gjennomført et forskningsopphold ved UCSD i USA. Se intervju nedenfor.

Published Sep. 5, 2019 10:46 AM

In collaboration with UiO FOCIS CoE, K.G. Jebsen Centre for Cancer Immunology is hosting a symposium with Visiting Professor Peter Parham from Stanford University, USA, and Erik Dissen from the University of Oslo.

The former president, Christoph Huber, and the new president, Özlem Tureci, together with newly elected member of the Executive Board, Johanna Olweus
Published June 10, 2019 8:51 PM

Johanna Olweus, Head of Dept of Cancer Immunology at the Institute for Cancer Research, OUS Radiumhospitalet, and Professor at the University of Oslo, was May 21st elected member of the executive board of CIMT during the CIMT 2019 conference in Mainz, Germany. 

Published Nov. 30, 2018 12:14 PM

The Olweus group obtained grant from the BIOTEK 2021 programme at the Research Council of Norway for the project "Treating lymphoma with novel immunotherapy".

Published Nov. 30, 2018 12:11 PM

The Knut and Alice Wallenberg Foundation has awarded a total of SEK 640 million to 22 research projects in the fields of medicine, science and technology that are considered to offer potential for future scientific breakthroughs.

Published Nov. 30, 2018 12:04 PM

Dagens Medisin highlights mapping of the human genome and cancer immunotherapy as among the greatest medical breakthroughs since 1998 in an article series looking at the medical advances the last 20 years.

Published Feb. 13, 2018 8:04 AM

Jodie Goodridge and Karl-Johan Malmberg have received a grant from The Research Council of Norway (RCN) Toppforsk for the project "Programming natural killer cell function through the organelle communication". Their application was among the 16% that was granted.

Published Feb. 5, 2018 1:10 PM

Senterleder Johanna Olweus i intervju med Aftenposten Vitenskap om sitt arbeid innenfor immunterapi.

Published Nov. 17, 2017 9:56 AM

Karl-Johan Malmberg has received funding from The Norwegian Cancer Society of 8,95 mill. NOK.

Published Oct. 19, 2017 2:46 PM

The research group of Johanna Olweus, together with Kite Pharma, will further develop breakthrough technology on immunotherapy against cancer.

Published Aug. 3, 2017 9:41 AM

The conference explores possibilities for how to create a leading Nordic Life Science hub for research, education, innovation and business focusing this year on health.

Published Aug. 2, 2017 11:21 AM

Every year The Norwegian Cancer Society supports cancer Research. In 2016 a total of 40 million NOK was granted to immunotherapy.

Published July 31, 2017 1:22 PM

In connection with American Society of  Clinical Oncology (ASCO) naming immunotherapy as the Society’s advance of the year, Professor Johanna Olweus and Professor Karl-Johan Malmberg was interviewed by Dagens Medisin, April 12th 2017.

Published Mar. 15, 2017 3:31 PM

Malmberg Lab enter into partnership with Fate Therapeutics Inc. to develop off-the-shelf NK cell therapy

Published Nov. 28, 2016 12:41 PM

Professor and co-Director of K.G. Jebsen Centre of Immunotherapy Karl-Johan Malmberg speaks on "Harnessing Natural Killer Cells in Cancer Immunotherapy" during STREAM mini-symposium.

Published Nov. 22, 2016 12:24 PM

JCIT Director Professor Johanna Olweus was invited to present immunotherapy, current strategies and comment on K.G. Jebsen Centre’s current work.

Published Nov. 18, 2016 9:39 AM

Oslo University Hospital gives prizes to six outstanding research articles with key authors from the hospital every six months.

Published Mar. 11, 2016 12:58 PM
Published Mar. 3, 2016 11:37 AM
Published Feb. 16, 2016 11:37 AM
Published Dec. 1, 2015 2:27 PM

Researchers from the KG Jebsen Centres for Cancer Immunotherapy (JCIT) and Inflammation Research (JIRC) collaborate to develop tomorrow's tools for protein analysis.

Published Sep. 9, 2015 9:53 AM
Published Sep. 9, 2015 9:34 AM

Karl-Johan Malmberg, PI in the Jebsen Center for cancer Immunotherapy has been appointed as visiting professor at the Karolinska Institute (KI).